IP Verse

Fujirebio Diagnostics, Inc. vs Quanterix Corp.

The detailed information for PTAB case with proceeding number IPR2025-01060 filed by Fujirebio Diagnostics, Inc. against Quanterix Corp. on May 28, 2025. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2025-01060
Filing Date: May 28, 2025
Petitioner: Fujirebio Diagnostics, Inc.
Respondent: Quanterix Corp.
Status: Pending
Respondent Application Number: 16522237
Respondent Tech Center: 1600
Respondent Patent Number: 11275092

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Petitioner's Updated Mandatory Notice	Jul 1, 2025	PAPER	PETITIONER
Notice: Notice filing date accorded	Jun 20, 2025	PAPER	BOARD
Notice: Mandatory Notice	Jun 16, 2025	PAPER	PATENT OWNER
Notice: Power of Attorney	Jun 16, 2025	PAPER	PATENT OWNER
EX-1001 U.S. Patent No. 11,275,092 (“the ’092 Patent”)	May 28, 2025	EXHIBIT	PETITIONER
EX-1004 Curriculum vitae of Petitioner’s Expert John Todd, PhD	May 28, 2025	EXHIBIT	PETITIONER
EX-1005 Single-molecule enzyme-linked immunosorbent assay detects serum pro	May 28, 2025	EXHIBIT	PETITIONER
EX-1006 How Low Can You Go?	May 28, 2025	EXHIBIT	PETITIONER
EX-1007 Diagnostic Method For Alzheimer’s Disease By Screening For Tau-Pept	May 28, 2025	EXHIBIT	PETITIONER
EX-1008 File History of US application No. 08/159,969	May 28, 2025	EXHIBIT	PETITIONER
EX-1009 Digital Concentration Readout of Single Enzyme Molecules Using Femt	May 28, 2025	EXHIBIT	PETITIONER
EX-1010 Simultaneous Detection of Single Molecules and Singulated Ensembles	May 28, 2025	EXHIBIT	PETITIONER
EX-1011 Next-Generation Diagnostics A startup can detect tiny traces	May 28, 2025	EXHIBIT	PETITIONER
EX-1012 Ultrasensitive Flow-based Immunoassays Using Single-Molecule	May 28, 2025	EXHIBIT	PETITIONER
EX-1013 Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive	May 28, 2025	EXHIBIT	PETITIONER
EX-1014 Nanoparticle-based bio-barcode assay redefines	May 28, 2025	EXHIBIT	PETITIONER
EX-1015 Duffy et al., US2010/0075407	May 28, 2025	EXHIBIT	PETITIONER
EX-1016 Digital Readout of Target Binding with Attomole	May 28, 2025	EXHIBIT	PETITIONER
EX-1017 Neuron-specific enolase and tau protein as neurobiochemical markers	May 28, 2025	EXHIBIT	PETITIONER
EX-1018 Assessment of the Cerebral Ischemic/Reperfusion Injury	May 28, 2025	EXHIBIT	PETITIONER
EX-1019 Ding et al., Transl Neurodegener	May 28, 2025	EXHIBIT	PETITIONER
EX-1020 The Role of Tau in Alzheimer’s Disease and Related Disorders	May 28, 2025	EXHIBIT	PETITIONER
EX-1021 A protein factor essential for microtubule assembly	May 28, 2025	EXHIBIT	PETITIONER
EX-1002 Select portions of prosecution history of the ’092 Patent Pt. 1	May 28, 2025	EXHIBIT	PETITIONER
EX-1002 Select portions of prosecution history of the ’092 Patent Pt. 2	May 28, 2025	EXHIBIT	PETITIONER
EX-1023 Konzack et a., “Swimming against the Tide: Mobility of the	May 28, 2025	EXHIBIT	PETITIONER
EX-1024 INNOTEST hTAU Ag	May 28, 2025	EXHIBIT	PETITIONER
EX-1025 Biomarkers for Alzheimer’s disease – Clinical needs and application	May 28, 2025	EXHIBIT	PETITIONER
EX-1026 Detection of τ Proteins in Normal and Alzheimer’s Disease	May 28, 2025	EXHIBIT	PETITIONER
EX-1027 Tau as a Marker for Early CNS Damage	May 28, 2025	EXHIBIT	PETITIONER
EX-1028 Monoclonal Antibodies Directed Against the Microtubule-Associated	May 28, 2025	EXHIBIT	PETITIONER
EX-1029 Current state and future directions of neurochemical biomarkers	May 28, 2025	EXHIBIT	PETITIONER
EX-1031 Tau as a biomarker of neurodegenerative diseases	May 28, 2025	EXHIBIT	PETITIONER
EX-1032 CSF markers for incipient Alzheimer’s disease	May 28, 2025	EXHIBIT	PETITIONER
EX-1033 Quanterix Single Molecule Arrays for Digital Detection in Complex	May 28, 2025	EXHIBIT	PETITIONER
EX-1034 simoa Assay Kits	May 28, 2025	EXHIBIT	PETITIONER
EX-1035 Single-Molecule Detection for Femtomolar Quantification of Proteins	May 28, 2025	EXHIBIT	PETITIONER
EX-1036 Singulex	May 28, 2025	EXHIBIT	PETITIONER
EX-1037 Mild traumatic brain injury: a risk factor for neurodegeneration	May 28, 2025	EXHIBIT	PETITIONER
EX-1038 Head trauma as a risk factor for Alzheimer’s disease	May 28, 2025	EXHIBIT	PETITIONER
EX-1039 Quanterix Announces Commercial Availability of its Simoa Single	May 28, 2025	EXHIBIT	PETITIONER
EX-1040 Quanterix Issued Key Patent for Simoa™ Technology	May 28, 2025	EXHIBIT	PETITIONER
EX-1041 Quanterix Announces Key Patents Issued for Simoa Platform	May 28, 2025	EXHIBIT	PETITIONER
EX-1042 Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau	May 28, 2025	EXHIBIT	PETITIONER
Notice: Power of Attorney	May 28, 2025	PAPER	PETITIONER
EX-1043 Declaration of Ingrid	May 28, 2025	EXHIBIT	PETITIONER
EX-1043 Declaration of Ingrid Pt. 2	May 28, 2025	EXHIBIT	PETITIONER
EX-1003 Expert Declaration	May 28, 2025	EXHIBIT	PETITIONER
Petition: as filed	May 28, 2025	PAPER	PETITIONER
EX-1030 Alzheimer's Disease	May 28, 2025	EXHIBIT	PETITIONER